De novo synthesis of two new cytotoxic tiazofurin analogues with modified sugar moieties

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 19, 2003, Pages 3167-3170

  Popsavin, Mirjana ^a   Torović, Ljilja ^a   Kojić, Vesna ^b   Bogdanović, Gordana ^b   Spaić, Saša ^a   Popsavin, Velimir ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b Inst of Oncology Sremska Kamenica   (Yugoslavia)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 ACETAMIDO 3 DEOXY BETA DEXTRO XYLOFURANOSYL)THIAZOLE 4 CARBOXAMIDE; 2 (3 DEOXY 3 FLUORO BETA DEXTRO XYLOFURANOSYL)THIAZOLE 4 CARBOXAMIDE; CYTOTOXIC AGENT; GLUCOSE; NUCLEOSIDE; SUGAR; THIAZOLE DERIVATIVE; TIAZOFURIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; SOLID TUMOR; TUMOR CELL LINE;

EID: 0041831043     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00712-1     Document Type: Article

References (28)

1. For a brief overview of the molecular, biological and clinical impact of tiazofurin, see: Grifantini, M. Curr. Opin. Invest. Drugs, 2000, 1, 257.
2. Weber G., Prajada N., Abonyi M., Look K.Y., Tricot G. Anticancer Res. 16:1996;3313.
3. Lui M.S., Faderan M.A., Liepnieks J.J., Natsumeda Y., Olah E., Jayaram H.N., Weber G. J. Biol. Chem. 259:1984;5078.
4. (a) Konno Y., Natsumeda Y., Nagai M., Yamaji Y., Ohno S., Suzuki K., Weber G. J. Biol. Chem. 266:1991;506
5. (b) Natsumeda Y., Ohno S., Kawasaki H., Konno Y., Weber G., Suzuki K. J. Biol. Chem. 265:1990;5292.
6. Jayaram H.N., Grusch M., Cooney D.A., Krupitza G. Curr. Med. Chem. 6:1999;561.
7. Colby T.D., Vanderveen K., Strickler M.D., Markham G.D., Goldstein B.M. Proc. Natl. Acad. Sci. U.S.A. 96:1999;3531.
8. (a) For recent approaches to tiazofurin see: Brown R.S., Dowden J., Moreau C., Potter B.V.L. Tetrahedron. Lett. 43:2002;6561
9. (b) Ramasamy K.S., Banderu R., Averett D. J. Org. Chem. 65:2000;5849
10. (c) Ramasamy K.S., Averett D. Nucleosides Nucleotides. 18:1999;2425.
11. Franchetti P., Marchetti S., Cappellacci L., Yalowitz J.A., Jayaram H.N., Goldstein B.M., Grifantini M. Bioorg. Med. Chem. Lett. 11:2001;67. and references therein.
12. (a) 5′-Subsituted analogues: Srivastava P.C., Pickering M.V., Allen L.B., Streeter D.G., Campbell M.T., Witkowski J.T., Sidwell R.W., Robins R.K. J. Med. Chem. 20:1977;256
13. (b) Hanna N.B., Upadhya K.G., Petrie C.R., Robins R.K., Revankar G.R. Nucleosides Nucleotides. 5:1986;343
14. (c) Andrés J.I., Garcia-López M.T., De las Heras F.G., Méndez-Castrilón P.P. Nucleosides Nucleotides. 5:1986;423.
15. 3′-Substituted analogues: Baur R.H., Baker D.C. Nucleosides Nucleotides. 3:1984;77.
16. 2′-Substituted analogues: Jayaram H.N., Dion R.L., Glazer R.I., Johns D.G., Robins R.K., Srivastava P.C., Cooney D.A. Biochem. Pharmacol. 31:1982;2371.
17. Mao D.T., Marquez V.E. Tetrahedron Lett. 25:1984;2111.
18. Kovacs L., Herczegh P., Batta G., Farkas I. Tetrahedron. 47:1991;5539.
19. Kovacs L., Herczegh P., Batta G., Farkas I. Heterocycles. 26:1987;947.
20. Dishington A.P., Humber D.C., Stoodley R.J. J. Chem. Soc., Perkin Trans. 1. 1993;57.
21. Kini G.D., Hennen W.J. J. Org. Chem. 51:1986;4436.
22. Popsavin M., Popsavin V., Vukojević N., Csanádi J., Miljković D. Carbohydr. Res. 260:1994;145.
23. Popsavin M., Torović Lj., Spaić S., Stankov S., Kapor A., Tomić Z., Popsavin V. Tetrahedron. 58:2002;569.
24. 7: C, 63.46; H, 5.08.
25. ++1).
26. 8Na: 478.1478.
27. 5S: C, 43.85; H, 5.02; N, 13.95; S, 10.64.
28. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., Boyd M.R. Cancer Res. 48:1988;4827.